Weakened by strengths: drugs in solution, medication error and drug safety by Wheeler, D

Curriculum process / by 216640 Wheeler, D. K.

Chronic kidney disease: Does serum phosphate predict death and ESRD in CKD patients? by Haynes, R, Wheeler, D

Should we reduce blood cholesterol to prevent cardiovascular disease among patients with chronic renal failure? by Baigent, C, Wheeler, D

Chronic kidney disease: Does serum phosphate predict death and ESRD in CKD patients? by Haynes, R, Wheeler, D

Premature cardiovascular disease in chronic renal failure. by Baigent, C, Burbury, K, Wheeler, D

Misleading associations between cholesterol and vascular outcomes in dialysis patients: the need for randomized trials. by Baigent, C, Landray, M, Wheeler, D

Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. by Wheeler, D, Townend, J, Landray, M

Two-year survival among patients with chronic-kidney disease not on dialysis: The chronic renal impairment in Birmingham (CRIB) study. by Nuttall, S, Landray, M, Townend, J, Ball, S, Wheeler, D

Influence of experimental warming and shading on host-parasitoid synchrony by Klapwijk, M, Groebler, B, Ward, K, Wheeler, D, Lewis, O

Identification of an oncogenic RAB protein by Wheeler, D. B., Zoncu, R., Root, D. E., Sawyers, C. L., Sabatini, David

Get full text
Get full text

SERUM LIPIDS DO NOT PREDICT CARDIOVASCULAR OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS by Landray, M, Blackwell, L, Morgan, M, Nuttall, S, Baigent, C, Townend, J, Wheeler, D

Optical detection of the anesthetic agent propofol in the gas phase. by Laurila, T, Sorvajärvi, T, Saarela, J, Toivonen, J, Wheeler, D, Ciaffoni, L, Ritchie, G, Kaminski, C

Serum free light chains and the risk of ESRD and death in CKD by Haynes, R, Hutchison, C, Emberson, J, Dasgupta, T, Wheeler, D, Townend, J, Landray, M, Cockwell, P

Serum free light chains and the risk of ESRD and death in CKD. by Haynes, R, Hutchison, C, Emberson, J, Dasgupta, T, Wheeler, D, Townend, J, Landray, M, Cockwell, P

ELEVATED LEVELS OF N-TERMINAL BRAIN NATRIURETIC PEPTIDE AND TROPONIN T CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS by Landray, M, Ayrton, P, Blackwell, L, Nuttall, S, Nair, D, Townend, J, Baigent, C, Wheeler, D

ELEVATED LEVELS OF ASYMMETRIC DIMETHYLARGININE (ADMA) AND SYMMETRIC DIMETHYLARGININE (SDMA) CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS by Landray, M, Dalton, N, Turner, C, Blackwell, L, Morgan, M, Nuttall, S, Baigent, C, Townend, J, Wheeler, D

Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. by Landray, M, Thambyrajah, J, McGlynn, F, Jones, H, Baigent, C, Kendall, M, Townend, J, Wheeler, D

Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. by Landray, M, Wheeler, D, Lip, G, Newman, D, Blann, A, McGlynn, F, Ball, S, Townend, J, Baigent, C

Smoking benefits celiac sprue and pouchitis: implications for nicotine therapy? by Snook, J, Dwyer, L, Lee-Elliott, C, Knan, S, Wheeler, D, Nicholas, D, Merrett, M, Mortensen, N, Kettlewell, Jewell, D